<html><body><h2>Case: 1328208</h2><h3> CDS Time: 1962-06-15</h3>
<patient name=1328208>
62.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">62</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">7</td><td width="200">1960-6-4</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">7</td><td width="200">1960-6-4</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">84</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1958-10-20</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">86</td><td width="200">1961-10-17</td></tr>
<tr><td width="200">Chloride</td><td width="200">94.0</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">34</td><td width="200">1961-10-17</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">56</td><td width="200">1962-4-13</td></tr>
<tr><td width="200">BNP</td><td width="200">373</td><td width="200">1961-7-13</td></tr>
<tr><td width="200">B 12</td><td width="200">634.0</td><td width="200">1960-5-31</td></tr>
<tr><td width="200">Weight</td><td width="200">208</td><td width="200">1962-4-13</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">7</td><td width="200">1959-7-12</td></tr>
<tr><td width="200">Creatinine_Clearance</td><td width="200">113</td><td width="200">1958-10-15</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">309</td><td width="200">1961-10-17</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">150</td><td width="200">1961-10-17</td></tr>
<tr><td width="200">SGOT</td><td width="200">34</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">131</td><td width="200">1962-4-13</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">2</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Height</td><td width="200">67</td><td width="200">1962-4-13</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">150</td><td width="200">1961-10-17</td></tr>
<tr><td width="200">BUN</td><td width="200">14</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">HCT</td><td width="200">52</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">HGB</td><td width="200">16</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Sodium</td><td width="200">129</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Creatinine</td><td width="200">0.9</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">7.0</td><td width="200">1960-6-4</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">7</td><td width="200">1960-6-4</td></tr>
<tr><td width="200">Pulse</td><td width="200">76</td><td width="200">1962-4-13</td></tr>
<tr><td width="200">PLT</td><td width="200">177</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">WBC</td><td width="200">12</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">eGFR</td><td width="200">60</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">SGPT</td><td width="200">64</td><td width="200">1962-4-9</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1962-1-15</td></tr>
<tr><td width="200">Hepatitis_C_Status</td><td width="200">Negative</td><td width="200">1960-6-2</td></tr>
<tr><td width="200">Hepatitis_B_Surface_Antigen</td><td width="200">Negative</td><td width="200">1960-6-2</td></tr>
<tr><td width="200">heart</td><td width="200"></td><td width="200">1962-4-16</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1961-10-14</td></tr>
<tr><td width="200">Depression</td><td width="200"></td><td width="200">1962-6-11</td></tr>
<tr><td width="200">complications of transplant</td><td width="200"></td><td width="200">1962-4-16</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1961-3-31</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1961-3-26</td></tr>
</table>
<p><b>Medications:</b> cyclosporine(75.0) aspirin(325.0) spironolactone(25.0) lisinopril(1.0) nitrate(120.0) furosemide(40.0) pravastatin(40.0) Insulin(2.0) clonidine(0.6) atorvastatin(80.0) carvedilol(12.5) digoxin(0.125) hydralazine(0.0) hydrochlorothiazide(25.0) glipizide(5.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Transplant recipients</td>
<td width="200">1962-04-16</td>
<td width="200"> heart()</td></tr>
<tr> <td width="200"></td>
<td width="200">1962-04-16</td>
<td width="200"> complications of transplant()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(129.0/1962-4-9)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Significant hyponatremia[Sodium(129.0/1962-4-9)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[HDL_Cholesterol(34.0/1961-10-17)]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(56/null) && Treatment_Systolic_BP(131/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Sodium=<125 ever</td>
<td width="200"></td>
<td width="200"> hyponatremia in the past[Sodium(129.0/1962-4-9)]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(56/null) && Treatment_Systolic_BP(131/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[HDL_Cholesterol(34.0/1961-10-17)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Active prescription for ACE and aldosterone antagonists</td>
<td width="200"></td>
<td width="200"> Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGPT(64.0/1962-4-9)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1961-03-31</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1961-03-26</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1962-01-15</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1962-06-11</td>
<td width="200"> Depression()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1961-10-14</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1960-06-02</td>
<td width="200"> Hepatitis_C_Status()
<tr> <td width="200"></td>
<td width="200">1960-06-02</td>
<td width="200"> Hepatitis_B_Surface_Antigen()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: carvedilol Reaction: 
<li>Substance: carvedilol Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(86.0/1961-10-17))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(56/null) && Treatment_Systolic_BP(131/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>aldosterone antagonist<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>Already being used<li>Adverse events:  (Beta_Blocker Stage C Heart Failure)  (Beta_Blocker Stage C Heart Failure) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>Beta Blocker Stage B no MI<ul><li>preference: neutral<li>No comment</ul><li>ARB<ul><li>Relative contraindications:  Active prescription for ACE and aldosterone antagonists(Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]) <li>preference: neutral</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Already being used<li>preference: ruled out</ul><li>digoxin<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>Already being used<li>Adverse events:  (Beta blocker stage B post MI)  (Beta blocker stage B post MI) <li>preference: ruled out</ul></ul></body></html>